Abstract:Objective: This study aims to investigate the effect of nimodipine combined with betahistine on the levels of CRP and other inflammatory cytokines, as well as vascular endothelial function in patients with hypertensive cerebral vasospasm. Methods: A total of 80 patients with hypertensive cerebral vasospasm from March 2016 to September 2018 were enrolled and randomly equally divided into two groups. At 1 week before enrollment, the application of all antihypertensive drugs was stopped. Then amlodipine tablets were used in control group, based on which nimodipine tablets were applied in observation group. All the patients included were followed up for 1 month. The changes in the cerebral vasospasm index in the course of treatment as well as inflammatory cytokines and indicators related to vascular endothelial function at 1 month after treatment were measured and compared between the two groups. The correlations of the cerebral vasospasm index with the changes in inflammatory cytokines and vascular endothelial function-related factors in the body were analyzed. Finally, the effective rates of blood pressure regulation and cerebral vasospasm treatment were compared, while the adverse reactions and the overall clinical treatment effect of the two groups were evaluated. Results: The cerebral vasospasm indexes in observation group were significantly lower than those in control group at 3 d, 1 week and 1 month after treatment (p < 0.05). At 1 month after treatment, the levels of inflammatory cytokines such as high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in observation group were significantly reduced compared to those in control group (p < 0.05). As for vascular endothelial function-related indicators, the endothelin-1 (ET-1) level in observation group was markedly lower than that in control group, whereas the level of nitric oxide (NO) was statistically higher than that in control group (p < 0.05). The cerebral vasospasm index was statistically positively correlated with changes in hs-CRP, IL-6, TNF-α and ET-1 (p < 0.05), but negatively correlated with changes in NO (p < 0.05). Besides, the effective rates of blood pressure regulation and cerebral vasospasm treatment in observation group were significantly higher than those in control group (p < 0.05). The overall treatment effective rate in observation group was markedly higher than that in control group (p < 0.05), and there were no significant differences of adverse reactions between the two groups (p > 0.05). Conclusion: For the treatment of hypertensive cerebral vasospasm, combined application of betahistine on the basis of nimodipine can effectively reduce the body's aseptic inflammatory responses, improve vascular endothelial function and increase the cerebral circulation blood flow, which offers a favorable strategy for clinical therapy.

The effect of Nimodipine on plasma NSE levels and the prognosis after hypertensive intracerebral hemorrhage

The Efficacy and Safety of Nimodipine in Acute Ischemic Stroke Patients with Mild Cognitive Impairment: a Double-Blind, Randomized, Placebo-Controlled Trial

Effect of Xingnaojing Injection on nitric oxide, insulin-like growth factor-1 and macrophage inhibitory factor of hypertensive patients with intracerebral hemorrhage

Value of neuroendoscope in the treatment of hypertensive cerebral hemorrhage in the emergency department

The Experimental Study of Ginkgolide B Effectual on Neuronal Cell Apoptosis in the Rat with Intracerebral Hemorrhage

The Therapeutic Effect of Nimodipine in Treatment of Severe Traumatic Brain Injuries with Subarachoid Hemorrhage

Value of cerebrovascular hemodynamic indexes in the dosing of nimodipine followed subarachnoid hemorrhage

Effect of Nimodipine to the Nerve Function and the MMP-9 in the Patients of Acute Cerebral Infarction

Clinical Efficacy and Prognosis of Naoxueshu Oral Liquid Combined with Nifedipine in the Treatment of Patients with Hypertensive Intracerebral Hemorrhage

Effect of intravenous nimodipine on blood pressure and outcome after acute stroke

Acute Effects of Nimodipine on Cerebral Vasculature and Brain Metabolism in High Grade Subarachnoid Hemorrhage Patients

Study on the Treatmental Effect of Nimodipine to Hypoxic-Ischemic Encephalopathy in the Neonates

The Effect of Nimodipine on the Evolution of Human Cerebral Infarction Studied by PET

Effect observation of nimodipine combined with atorvastatin in the prevention of cerebral vasospasm after subarachnoid hemorrhage and effect on ET-1 and NO

Effects of Topical Administration of Nimodipine on Cerebral Blood Flow Following Subarachnoid Hemorrhage in Pigs.

Effect of Nimodipine on Regional Cerebral Glucose Metabolism in Patients with Acute Ischemic Stroke as Measured by Positron Emission Tomography

Effect Western Medicines Combined With Nao-Xue-Shu in Patients With Hypertensive Intracerebral Hemorrhage: A Network Meta-Analysis

Nimodipine Attenuates Early Brain Injury by Protecting the Glymphatic System After Subarachnoid Hemorrhage in Mice

Effects of nimodipine combined with betahistine on CRP and other inflammatory cytokines and vascular endothelial function in patients with hypertensive cerebral vasospasm

Investigating the therapeutic effects of nimodipine on vasogenic cerebral edema and blood-brain barrier impairment in an ischemic stroke rat model

Nimodipine Improves Cognitive Impairment After Subarachnoid Hemorrhage in Rats Through IncRNA NEAT1/miR-27a/MAPT Axis